Ming-Yi Xu

Ming-Yi Xu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2017 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
YQYing Qu
Ying Qu
QZQidi Zhang
Qidi Zhang
XCXiaobo Cai
Xiaobo Cai
FLFei Li
Fei Li
ZMZhenzeng Ma
Zhenzeng Ma
LLLungen Lu
Lungen Lu
Proliferating hepatic stellate cells (HSCs) respond to liver damage by secreting collagens that form fibrous scar tissue, which can lead to cirrhosis if in appropriately regulated. Advancement of microRNA (miRNA) hepatic therapies has been hampered by difficulties in delivering miRNA to damaged tissue. However, exosomes secreted by adipose‐derived mesenchymal stem cells (ADSCs) can be exploited to deliver miRNAs to HSCs. ADSCs were engineered to overexpress miRNA‐181‐5p (miR‐181‐5p‐ADSCs) to selectively home exosomes to mouse hepatic stellate (HST‐T6) cells or a CCl4‐induced liver fibrosis murine model and compared with non‐targeting control Caenorhabditis elegans miR‐67 (cel‐miR‐67)‐ADSCs. In vitro analysis confirmed that the transfer of miR‐181‐5p from miR‐181‐5p‐ADSCs occurred via secreted exosomal uptake. Exosomes were visualized in HST‐T6 cells using cyc3‐labelled pre‐miRNA‐transfected ADSCs with/without the exosomal inhibitor, GW4869. The effects of miRNA‐181‐5p overexpression on the fibrosis associated STAT3/Bcl‐2/Beclin 1 pathway and components of the extracellular matrix were assessed. Exosomes from miR181‐5p‐ADSCs down‐regulated Stat3 and Bcl‐2 and activated autophagy in the HST‐T6 cells. Furthermore, the up‐regulated expression of fibrotic genes in HST‐T6 cells induced by TGF‐β1 was repressed following the addition of isolated miR181‐5p‐ADSC exosomes compared with miR‐67‐ADSCexosomes. Exosome therapy attenuated liver injury and significantly down‐regulated collagen I, vimentin, α‐SMA and fibronectin in liver, compared with controls. Taken together, the effective anti‐fibrotic function of engineered ADSCs is able to selectively transfer miR‐181‐5p to damaged liver cells and will pave the way for the use of exosome‐ADSCs for therapeutic delivery of miRNA targeting liver disease.

1 February 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
BWBin Wang
Bin Wang
TLTing Liu
Ting Liu
JWJun-Cheng Wu
Jun-Cheng Wu
SLSheng-Zheng Luo
Sheng-Zheng Luo
RCRong Chen
Rong Chen
MXMing-Yi Xu
Ming-Yi Xu

14 April 2021 in World Journal of Gastroenterology
Verified
Journal Article
Open access
XLXin Luo
Xin Luo
SLSheng-Zheng Luo
Sheng-Zheng Luo
ZXZi-Xin Xu
Zi-Xin Xu
CZCui Zhou
Cui Zhou
ZLZheng-Hong Li
Zheng-Hong Li
MXMing-Yi Xu
Ming-Yi Xu
Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease

3 November 2021 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
XLXin Luo
Xin Luo
ZXZi-Xin Xu
Zi-Xin Xu
JWJun-Cheng Wu
Jun-Cheng Wu
SLSheng-Zheng Luo
Sheng-Zheng Luo
MXMing-Yi Xu
Ming-Yi Xu
The role of exosome-mediated mitophagy in the crosstalk between hepatocytes (HCs) and hepatic stellate cells (HSCs) in metabolic-associated fatty liver disease (MAFLD) remains unknown. Serum exosomal miR-27a levels were markedly increased and positively correlated with liver fibrosis in MAFLD patients and mice. Exosomal miR-27a was released from lipotoxic HCs and specifically transmitted to recipient-activated HSCs. PINK1, the key target of miR-27a, primarily mediates mitophagy. Overexpression of miR-27a or knockdown of PINK1 or lipotoxic HC-exosomal miR-27a impaired mitochondria (inhibiting mitophagy, respiration, membrane potential, and transcription while promoting reactive oxygen species production) in activated HSCs and stimulated HSC-derived fibroblasts (promoting activation and proliferation while inhibiting autophagy). High exosomal miR-27a serum levels and a lack of hepatic PINK1-mediated mitophagy were directly related to liver fibrosis in MAFLD mice. Lipotoxic HC exosome transplantation aggravated the degree of PINK1-mediated mitophagy suppression, steatohepatitis, lipidosis, and fibrosis in the livers of MAFLD mice with cirrhosis. Both in vitro and in vivo, exosomes derived from miR-27a-knockdown HCs could not facilitate the abovementioned deteriorating effects. In conclusion, lipotoxic HC-exosomal miR-27a plays a pivotal role in inhibiting mitophagy and in promoting MAFLD-related liver fibrosis by negatively regulating PINK1 expression.

15 February 2024 in Aging
Verified
Journal Article
Open access
PDF file
KWKui Wang
Kui Wang
JWJiawei Wang
Jiawei Wang
YCYuhua Chen
Yuhua Chen
HLHuan Long
Huan Long
WPWei Pan
Wei Pan
QGQiang Guo
Qiang Guo
Background: The causative implications remain ambiguous. Consequently, this study aims to evaluate the putative causal relationship between gut microbiota and Esophageal cancer (EC). Methods: The genome-wide association study (GWAS) pertaining to the microbiome, derived from the MiBioGen consortium-which consolidates 18,340 samples across 24 population-based cohorts-was utilized as the exposure dataset. Employing the GWAS summary statistics specific to EC patients sourced from the GWAS Catalog and leveraging the two-sample Mendelian randomization (MR) methodology, the principal analytical method applied was the inverse variance weighted (IVW) technique. Cochran’s Q statistic was utilized to discern heterogeneity inherent in the data set. Subsequently, a reverse MR analysis was executed. Results: Findings derived from the IVW technique elucidated that the Family Porphyromonadaceae (P = 0.048) and Genus Candidatus Soleaferrea (P = 0.048) function as deterrents against EC development. In contrast, the Genus Catenibacterium (P = 0.044), Genus Eubacterium coprostanoligenes group (P = 0.038), Genus Marvinbryantia (P = 0.049), Genus Ruminococcaceae UCG010 (P = 0.034), Genus Ruminococcus1 (P = 0.047), and Genus Sutterella (P = 0.012) emerged as prospective risk contributors for EC. To assess reverse causal effect, we used EC as the exposure and the gut microbiota as the outcome, and this analysis revealed associations between EC and seven different types of gut microbiota. The robustness of the MR findings was substantiated through comprehensive heterogeneity and pleiotropy evaluations. Conclusions: This research identified certain microbial taxa as either protective or detrimental elements for EC, potentially offering valuable biomarkers for asymptomatic diagnosis and prospective therapeutic interventions for EC.

18 September 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
JWJun-Cheng Wu
Jun-Cheng Wu
SLSheng-Zheng Luo
Sheng-Zheng Luo
TLTing Liu
Ting Liu
LLLun-Gen Lu
Lun-Gen Lu
MXMing-Yi Xu
Ming-Yi Xu
The biologic roles of long noncoding RNAs (lncRNAs) in liver fibrosis remained unknown. Through microarray analysis, linc‐SCRG1 (a lncRNA with transcript length 3118 bp) was found up‐regulated 13.62‐fold in human cirrhotic tissues. Quantitative PCR verified that linc‐SCRG1 increased along with liver fibrosis progression in human tissues and in activated LX2 cells induced by TGF‐β1. Knockdown of linc‐SCRG1 significantly reversed the effects of TGF‐β1 on LX2, including inhibiting activation, promoting apoptosis, reducing proliferation, lessening invasion, and down‐regulating genes [fibrosis‐related mRNA: α‐smooth muscle actin (α ‐SMA ), type I collagen, and B‐cell lymρhoma‐2; invasion‐related mRNA: matrix metalloρeρtidase‐2 ( MMP‐2 ), MMP‐9 , and MMP‐13 ; inflammation‐related mRNA: TNF‐ α , IL‐6 , and IL‐10 ]. linc‐SCRG1 had binding sites with tristetraprolin (TTP), a kind of RNA‐binding protein, and specifically combined to TTP proteins. Overexpression of linc‐SCRG1 would cause TTP mRNA unstably and proteins decreasing. TTP mRNA was proved having negative relevance with linc‐SCRG1 and was gradually reduced during human liver fibrosis progression. Overexpressing TTP resulted in knockdown of lincSCRG1 and degraded downstream target genes ( MMP‐2 and TNF‐ α) in activated LX2. Overexpressing TTP had the same effects as small interfering RNA‐lincSCRG1 (si ‐lincSCRG1 ), whereas knockdown of TTP had reversal effects on si‐ lincSCRG1 in activated LX2. In summary, linc‐SCRG1 reduced TTP and restricted its degradation of target genes TNF‐α and MMP‐2 . Therefore, linc‐SCRG1 had a repressing TTP‐elicited inactivation effect on hepatic stellate cell (HSC) phenotypes. Inhibition of linc‐SCRG1 may be a novel therapeutic approach to inactivate HSCs and extenuate human liver fibrosis.—Wu, J.‐C., Luo, S.‐Z., Liu, T., Lu, L.‐G., Xu, M.‐Y. linc‐SCRG1 accelerates liver fibrosis by decreasing RNA‐binding protein tristetraprolin. FASEB J. 33, 2105–2115 (2019). www.fasebj.org